Harold Kohn - Publications

Affiliations: 
1973-1999 Chemistry University of Houston, Houston, TX, United States 
 1999- Medicinal Chemistry University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
biological mechanisms of therapeutic agents
Website:
http://www.chem.unc.edu/research/index.html?display=organic&content=kohn

91 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Lee H, Park KD, Torregrosa R, Yang XF, Dustrude ET, Wang Y, Wilson SM, Barbosa C, Xiao Y, Cummins TR, Khanna R, Kohn H. Substituted N-(biphenyl-4'-yl)methyl (R)-2-acetamido-3-methoxypropionamides: potent anticonvulsants that affect frequency (use) dependence and slow inactivation of sodium channels. Journal of Medicinal Chemistry. 57: 6165-82. PMID 25004277 DOI: 10.1021/Jm500707R  0.406
2013 Lee H, Gold AS, Yang XF, Khanna R, Kohn H. Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity. Bioorganic & Medicinal Chemistry. 21: 7655-62. PMID 24238903 DOI: 10.1016/J.Bmc.2013.10.031  0.328
2013 Park KD, Yang XF, Lee H, Dustrude ET, Wang Y, Khanna R, Kohn H. Discovery of lacosamide affinity bait agents that exhibit potent voltage-gated sodium channel blocking properties. Acs Chemical Neuroscience. 4: 463-74. PMID 23509982 DOI: 10.1021/Cn300188H  0.363
2012 King AM, Yang XF, Wang Y, Dustrude ET, Barbosa C, Due MR, Piekarz AD, Wilson SM, White FA, Salomé C, Cummins TR, Khanna R, Kohn H. Identification of the benzyloxyphenyl pharmacophore: a structural unit that promotes sodium channel slow inactivation. Acs Chemical Neuroscience. 3: 1037-49. PMID 23259039 DOI: 10.1021/Cn300129D  0.601
2012 Baruah PK, Dinsmore J, King AM, Salomé C, De Ryck M, Kaminski R, Provins L, Kohn H. Synthesis, anticonvulsant activity, and neuropathic pain-attenuating activity of N-benzyl 2-amino-2-(hetero)aromatic acetamides. Bioorganic & Medicinal Chemistry. 20: 3551-64. PMID 22546207 DOI: 10.1016/J.Bmc.2012.04.002  0.635
2011 King AM, De Ryck M, Kaminski R, Valade A, Stables JP, Kohn H. Defining the structural parameters that confer anticonvulsant activity by the site-by-site modification of (R)-N'-benzyl 2-amino-3-methylbutanamide. Journal of Medicinal Chemistry. 54: 6432-42. PMID 21861466 DOI: 10.1021/Jm200760A  0.665
2011 King AM, Salomé C, Salomé-Grosjean E, De Ryck M, Kaminski R, Valade A, Stables JP, Kohn H. Primary amino acid derivatives: substitution of the 4'-N'-benzylamide site in (R)-N'-benzyl 2-amino-3-methylbutanamide, (R)-N'-benzyl 2-amino-3,3-dimethylbutanamide, and (R)-N'-benzyl 2-amino-3-methoxypropionamide provides potent anticonvulsants with pain-attenuating properties. Journal of Medicinal Chemistry. 54: 6417-31. PMID 21861463 DOI: 10.1021/Jm200759T  0.659
2011 Wang Y, Wilson SM, Brittain JM, Ripsch MS, Salomé C, Park KD, White FA, Khanna R, Kohn H. Merging Structural Motifs of Functionalized Amino Acids and α-Aminoamides Results in Novel Anticonvulsant Compounds with Significant Effects on Slow and Fast Inactivation of Voltage-gated Sodium Channels and in the Treatment of Neuropathic Pain. Acs Chemical Neuroscience. 2: 317-322. PMID 21765969 DOI: 10.1021/Cn200024Z  0.35
2011 Park KD, Kim D, Reamtong O, Eyers C, Gaskell SJ, Liu R, Kohn H. Identification of a lacosamide binding protein using an affinity bait and chemical reporter strategy: 14-3-3 ζ. Journal of the American Chemical Society. 133: 11320-30. PMID 21692503 DOI: 10.1021/Ja2034156  0.35
2011 King AM, Salomé C, Dinsmore J, Salomé-Grosjean E, De Ryck M, Kaminski R, Valade A, Kohn H. Primary amino acid derivatives: compounds with anticonvulsant and neuropathic pain protection activities. Journal of Medicinal Chemistry. 54: 4815-30. PMID 21639114 DOI: 10.1021/Jm2004305  0.665
2011 Wang Y, Park KD, Salome C, Wilson SM, Stables JP, Liu R, Khanna R, Kohn H. Development and characterization of novel derivatives of the antiepileptic drug lacosamide that exhibit far greater enhancement in slow inactivation of voltage-gated sodium channels. Acs Chemical Neuroscience. 2: 90-106. PMID 21532923 DOI: 10.1021/Cn100089B  0.368
2010 Morieux P, Salomé C, Park KD, Stables JP, Kohn H. The structure-activity relationship of the 3-oxy site in the anticonvulsant (R)-N-benzyl 2-acetamido-3-methoxypropionamide. Journal of Medicinal Chemistry. 53: 5716-26. PMID 20614888 DOI: 10.1021/Jm100508M  0.77
2010 Park KD, Stables JP, Liu R, Kohn H. Proteomic searches comparing two (R)-lacosamide affinity baits: An electrophilic arylisothiocyanate and a photoactivated arylazide group. Organic & Biomolecular Chemistry. 8: 2803-13. PMID 20405068 DOI: 10.1039/C000987C  0.37
2010 Salomé C, Salomé-Grosjean E, Stables JP, Kohn H. Merging the structural motifs of functionalized amino acids and alpha-aminoamides: compounds with significant anticonvulsant activities. Journal of Medicinal Chemistry. 53: 3756-71. PMID 20394379 DOI: 10.1021/Jm100185C  0.366
2010 Salomé C, Salomé-Grosjean E, Park KD, Morieux P, Swendiman R, DeMarco E, Stables JP, Kohn H. Synthesis and anticonvulsant activities of (R)-N-(4'-substituted)benzyl 2-acetamido-3-methoxypropionamides. Journal of Medicinal Chemistry. 53: 1288-305. PMID 20041718 DOI: 10.1021/Jm901563P  0.78
2009 Park KD, Morieux P, Salomé C, Cotten SW, Reamtong O, Eyers C, Gaskell SJ, Stables JP, Liu R, Kohn H. Lacosamide isothiocyanate-based agents: novel agents to target and identify lacosamide receptors. Journal of Medicinal Chemistry. 52: 6897-911. PMID 19795888 DOI: 10.1021/Jm9012054  0.762
2009 Lee SH, Kohn H. Nucleophilic activation of a tetra-substituted mitomycin cyclic bis-disulfide. Chemical & Pharmaceutical Bulletin. 57: 149-57. PMID 19182404 DOI: 10.1248/Cpb.57.149  0.404
2009 LEGALL P, SAWHNEY KN, CONLEY JD, KOHN H. Synthesis of functionalized non-natural amino acid derivatives via amidoalkylation transformations International Journal of Peptide and Protein Research. 32: 279-291. DOI: 10.1111/J.1399-3011.1988.Tb01262.X  0.309
2008 Morieux P, Stables JP, Kohn H. Synthesis and anticonvulsant activities of N-benzyl (2R)-2-acetamido-3-oxysubstituted propionamide derivatives. Bioorganic & Medicinal Chemistry. 16: 8968-75. PMID 18789868 DOI: 10.1016/J.Bmc.2008.08.055  0.778
2005 Kohn H, Widger W. The molecular basis for the mode of action of bicyclomycin. Current Drug Targets. Infectious Disorders. 5: 273-95. PMID 16181146 DOI: 10.2174/1568005054880136  0.301
2005 Brogan AP, Widger WR, Bensadek D, Riba-Garcia I, Gaskell SJ, Kohn H. Development of a technique to determine bicyclomycin-rho binding and stoichiometry by isothermal titration calorimetry and mass spectrometry. Journal of the American Chemical Society. 127: 2741-51. PMID 15725032 DOI: 10.1021/Ja046441Q  0.662
2005 Brogan AP, Verghese J, Widger WR, Kohn H. Bismuth-dithiol inhibition of the Escherichia coli rho transcription termination factor. Journal of Inorganic Biochemistry. 99: 841-51. PMID 15708806 DOI: 10.1016/J.Jinorgbio.2004.12.019  0.684
2005 Lee SH, Kohn H. 7-N,7'-N'-(1",2"-Dithianyl-3",6"-dimethylenyl)bismitomycin C: synthesis and nucleophilic activation of a dimeric mitomycin. Organic & Biomolecular Chemistry. 3: 471-82. PMID 15678185 DOI: 10.1039/B414806A  0.39
2005 Skordalakes E, Brogan AP, Park BS, Kohn H, Berger JM. Structural mechanism of inhibition of the Rho transcription termination factor by the antibiotic bicyclomycin. Structure (London, England : 1993). 13: 99-109. PMID 15642265 DOI: 10.1016/J.Str.2004.10.013  0.679
2005 Jin AY, Kohn H, Béguin C, Andurkar SV, Stables JP, Weaver DF. A quantitative structure-activity relationship study for α-substituted acetamido-N-benzylacetamide derivatives - A novel anticonvulsant drug class Canadian Journal of Chemistry. 83: 37-45. DOI: 10.1139/V04-160  0.403
2005 Lee SH, Brodnick RL, Glish GL, Kohn H. 3,8,11,16-Tetrakis(aminomethyl)-1,2,9,10-tetrathia-cyclohexadecane tetra-trifluoroacetic acid: Synthetic precursor to a novel thio-substituted diamine Tetrahedron. 61: 1749-1754. DOI: 10.1016/J.Tet.2004.12.030  0.336
2004 Béguin C, LeTiran A, Stables JP, Voyksner RD, Kohn H. N-Substituted amino acid N'-benzylamides: synthesis, anticonvulsant, and metabolic activities. Bioorganic & Medicinal Chemistry. 12: 3079-96. PMID 15142567 DOI: 10.1016/J.Bmc.2004.02.043  0.375
2004 Kim MG, Bodor ET, Harden TK, Kohn H. C(8)-substituted 1-azabicyclo[3.3.1]non-3-enes: a novel scaffold for muscarinic receptor ligands. Bioorganic & Medicinal Chemistry. 12: 2357-67. PMID 15080933 DOI: 10.1016/J.Bmc.2004.02.016  0.332
2003 Vedejs E, Naidu BN, Klapars A, Warner DL, Li VS, Na Y, Kohn H. Synthetic enantiopure aziridinomitosenes: preparation, reactivity, and DNA alkylation studies. Journal of the American Chemical Society. 125: 15796-806. PMID 14677970 DOI: 10.1021/Ja030452M  0.558
2003 Béguin C, Andurkar SV, Jin AY, Stables JP, Weaver DF, Kohn H. Functionalized amido ketones: new anticonvulsant agents. Bioorganic & Medicinal Chemistry. 11: 4275-85. PMID 12951158 DOI: 10.1016/S0968-0896(03)00434-6  0.345
2003 Brogan AP, Widger WR, Kohn H. Bicyclomycin fluorescent probes: synthesis and biochemical, biophysical, and biological properties. The Journal of Organic Chemistry. 68: 5575-87. PMID 12839449 DOI: 10.1021/Jo030020U  0.677
2003 Kim MG, Bodor ET, Wang C, Harden TK, Kohn H. C(8) substituted 1-azabicyclo[3.3.1]non-3-enes and C(8) substituted 1-azabicyclo[3.3.1]nonan-4-ones: novel muscarinic receptor antagonists. Journal of Medicinal Chemistry. 46: 2216-26. PMID 12747793 DOI: 10.1021/Jm020572P  0.402
2003 Lee SH, Kohn H. Phosphine-assisted rearrangement of 4,5-dihydroxy-1,2-dithianes to 4-hydroxy-3-mercaptotetrahydrothiophenes Heterocycles. 60: 47-56. DOI: 10.3987/Com-02-9603  0.306
2002 LeTiran A, Stables JP, Kohn H. Design and evaluation of affinity labels of functionalized amino acid anticonvulsants. Journal of Medicinal Chemistry. 45: 4762-73. PMID 12361404 DOI: 10.1021/Jm020225F  0.401
2002 Shen M, LeTiran A, Xiao Y, Golbraikh A, Kohn H, Tropsha A. Quantitative structure-activity relationship analysis of functionalized amino acid anticonvulsant agents using k nearest neighbor and simulated annealing PLS methods. Journal of Medicinal Chemistry. 45: 2811-23. PMID 12061883 DOI: 10.1021/Jm010488U  0.303
2002 Na Y, Wang S, Kohn H. 7-N-(mercaptoalkyl)mitomycins: implications of cyclization for drug function. Journal of the American Chemical Society. 124: 4666-77. PMID 11971715 DOI: 10.1021/Ja0124313  0.625
2001 Na Y, Li VS, Nakanishi Y, Bastow KF, Kohn H. Synthesis, DNA cross-linking activity, and cytotoxicity of dimeric mitomycins. Journal of Medicinal Chemistry. 44: 3453-62. PMID 11585450 DOI: 10.1021/Jm010090Y  0.516
2001 Vincent F, Srinivasan J, Santillán A, Widger WR, Kohn H. C(5)-C(5a)-modified bicyclomycins: synthesis, structure, and biochemical and biological properties. The Journal of Organic Chemistry. 66: 2251-64. PMID 11281764 DOI: 10.1021/Jo0013150  0.355
2001 Na Y, Kohn H. Quinone-cyclized porfiromycins Heterocycles. 55: 1347-1363. DOI: 10.3987/Com-01-9215  0.568
2000 Vincent F, Openshaw M, Trautwein M, Gaskell SJ, Kohn H, Widger WR. Rho transcription factor: symmetry and binding of bicyclomycin. Biochemistry. 39: 9077-83. PMID 10924100 DOI: 10.1021/Bi000504+  0.318
2000 Vincent F, Widger WR, Openshaw M, Gaskell SJ, Kohn H. 5a-formylbicyclomycin: studies on the bicyclomycin-Rho interaction. Biochemistry. 39: 9067-76. PMID 10924099 DOI: 10.1021/Bi000503H  0.367
2000 Wang C, Kohn H. Formation of aromatic rings through enamine annulation Organic Letters. 2: 1773-5. PMID 10880223 DOI: 10.1021/Ol000093P  0.348
2000 Li VS, Reed M, Zheng Y, Kohn H, Tang M. C5 cytosine methylation at CpG sites enhances sequence selectivity of mitomycin C-DNA bonding. Biochemistry. 39: 2612-8. PMID 10704210 DOI: 10.1021/Bi991307H  0.303
1999 Andurkar SV, Stables JP, Kohn H. The anticonvulsant activities of N-benzyl 3-methoxypropionamides. Bioorganic & Medicinal Chemistry. 7: 2381-9. PMID 10632047 DOI: 10.1016/S0968-0896(99)00186-8  0.394
1999 Wang S, Kohn H. Studies on the mode of action of mitomycin C(7) aminoethylene disulfides (BMS-181174 and KW-2149): reactivity of 7-N-(mercaptoethyl)mitomycin C. Journal of Medicinal Chemistry. 42: 788-90. PMID 10072677 DOI: 10.1021/Jm9806796  0.324
1998 Riba I, Gaskell SJ, Cho H, Widger WR, Kohn H. Evidence for the location of bicyclomycin binding to the Escherichia coli transcription termination factor Rho. The Journal of Biological Chemistry. 273: 34033-41. PMID 9852059 DOI: 10.1074/Jbc.273.51.34033  0.349
1997 Huh N, Kogan TP, Kohn H. Synthesis of N-substituted 10-des(carbamoyloxy)-10-azidomitomycins Synthesis. 921-924. DOI: 10.1055/S-1997-1297  0.332
1997 Cho H, Park HG, Zhang X, Riba I, Gaskell SJ, Widger WR, Kohn H. Design, syntheses, and evaluations of bicyclomycin-based rho inactivators Journal of Organic Chemistry. 62: 5432-5440. DOI: 10.1021/Jo970575N  0.375
1996 Santillán A, Park Hg, Zhang X, Lee OS, Widger WR, Kohn H. Role of the [4.2.2] Bicyclic Unit in Bicyclomycin: Synthesis, Structure, Chemical, Biochemical, and Biological Properties. The Journal of Organic Chemistry. 61: 7756-7763. PMID 11667731 DOI: 10.1021/Jo961003Q  0.423
1996 Park Hg, Zhang X, Widger WR, Kohn H. Role of the C(1) Triol Group in Bicyclomycin: Synthesis and Biochemical and Biological Properties. The Journal of Organic Chemistry. 61: 7750-7755. PMID 11667730 DOI: 10.1021/Jo961002Y  0.37
1996 Choi D, Stables JP, Kohn H. The anticonvulsant activities of functionalized N-benzyl 2-acetamidoacetamides. The importance of the 2-acetamido substituent Bioorganic and Medicinal Chemistry. 4: 2105-2114. PMID 9022975 DOI: 10.1016/S0968-0896(96)00225-8  0.389
1996 Huh N, Rege AA, Yoo B, Kogan TP, Kohn H. Design, synthesis, and evaluation of mitomycin-tethered phosphorothioate oligodeoxynucleotides Bioconjugate Chemistry. 7: 659-669. PMID 8950485 DOI: 10.1021/Bc960060N  0.388
1996 Magyar A, Zhang X, Kohn H, Widger WR. The antibiotic bicyclomycin affects the secondary RNA binding site of Escherichia coli transcription termination factor Rho Journal of Biological Chemistry. 271: 25369-25374. PMID 8810302 DOI: 10.1074/Jbc.271.41.25369  0.326
1996 Choi D, Stables JP, Kohn H. Synthesis and anticonvulsant activities of N-benzyl-2-acetamidopropionamide derivatives Journal of Medicinal Chemistry. 39: 1907-1916. PMID 8627614 DOI: 10.1021/Jm9508705  0.394
1996 Wang S, Kohn H. Mitomycin betaines: Synthesis, structure, and solvolytic reactivity Journal of Organic Chemistry. 61: 9202-9206. DOI: 10.1021/Jo961378B  0.34
1996 Kohn H, Wang S. Studies on the mechanism of activation of C(7) ethylenediamine substituted mitomycins. Relevance to the proposed mode of action of BMY-25067 and KW-2149 Tetrahedron Letters. 37: 2337-2340. DOI: 10.1016/0040-4039(96)00279-1  0.358
1995 Park Hg, Zhang X, Moon Hs, Zwiefka A, Cox K, Gaskell SJ, Widger WR, Kohn H. Bicyclomycin and Dihydrobicyclomycin Inhibition Kinetics ofEscherichia colirho-Dependent Transcription Termination Factor ATPase Activity Archives of Biochemistry and Biophysics. 323: 447-454. PMID 7487110 DOI: 10.1006/Abbi.1995.0066  0.333
1994 Kohn H, Sawhney KN, Robertson DW, Leander JD. Anticonvulsant properties of N-substituted alpha,alpha-diamino acid derivatives. Journal of Pharmaceutical Sciences. 83: 689-91. PMID 8071822 DOI: 10.1002/Jps.2600830519  0.323
1994 Bardel P, Bolanos A, Kohn H. Synthesis and anticonvulsant activities of alpha-acetamido-N-benzylacetamide derivatives containing an electron-deficient alpha-heteroaromatic substituent. Journal of Medicinal Chemistry. 37: 4567-4571. PMID 7799408 DOI: 10.1021/Jm00052A017  0.336
1994 Zhang Z, Kohn H. The role of the C-1 triol group in bicyclomycin Journal of the Chemical Society, Chemical Communications. 1343-1344. DOI: 10.1039/C39940001343  0.368
1994 Zhang Z, Kohn H. Chemical, biochemical, and biological studies on select C(1) triol modified bicyclomycins Journal of the American Chemical Society. 116: 9815-9826. DOI: 10.1021/Ja00101A001  0.312
1994 Park HG, Vela MA, Kohn H. Synthesis and reactivity of bicyclomycin C(3′) amines Journal of the American Chemical Society. 116: 471-478. DOI: 10.1021/Ja00081A006  0.396
1992 Han I, Russell DJ, Kohn H. Studies on the mechanism of mitomycin C(1) electrophilic transformations: structure-reactivity relationships The Journal of Organic Chemistry. 57: 1799-1807. DOI: 10.1021/Jo00032A037  0.32
1992 Schiltz P, Kohn H. Sodium dithionite-mediated mitomycin C reductive activation processes Tetrahedron Letters. 33: 4709-4712. DOI: 10.1016/S0040-4039(00)61265-0  0.329
1991 Hong YP, Kohn H. Studies on the use of chromium dichlorate for the reductive activation of Mitomycin C Journal of the American Chemical Society. 113: 4634-4644. DOI: 10.1021/Ja00012A036  0.334
1990 Lee C‐, Kohn H. Anticonvulsant Properties of 3-Oxo- and 3-Imino-4-Substituted 1,2,5-Thiadiazolidine 1,1-Dioxides Journal of Pharmaceutical Sciences. 79: 716-718. PMID 2231335 DOI: 10.1002/Jps.2600790813  0.343
1990 Kohn H, J. Russell D. Development of a Hydrazine-mediated System for the Reductive Activation of Mitomycin C Heterocycles. 31: 223. DOI: 10.3987/Com-89-5270  0.348
1990 Lee CH, Kohn H. Intra- and intermolecular .alpha.-sulfamidoalkylation reactions The Journal of Organic Chemistry. 55: 6098-6104. DOI: 10.1021/Jo00312A013  0.354
1989 Sawhney KN, Kohn H. Mitomycin C analogues with a substituted hydrazine at position 7. Synthesis, spectral properties, and biological activity. Journal of Medicinal Chemistry. 32: 248-252. PMID 2909738 DOI: 10.1021/Jm00121A044  0.375
1988 Kohn H, Conley JD, Leander JD. Marked stereospecificity in a new class of anticonvulsants. Brain Research. 457: 371-5. PMID 3219563 DOI: 10.1016/0006-8993(88)90709-3  0.311
1988 Kohn H, Abuzar S, Korp JD, Zektzer AS, Martin GE. Structural studies of bicyclomycin Journal of Heterocyclic Chemistry. 25: 1511-1517. DOI: 10.1002/Jhet.5570250548  0.326
1987 Conley JD, Kohn H. Functionalized DL-amino acid derivatives. Potent new agents for the treatment of epilepsy. Journal of Medicinal Chemistry. 30: 567-574. PMID 3820228 DOI: 10.1021/Jm00386A021  0.362
1987 Kohn H, Zein N, Lin XQ, Ding JQ, Kadish KM. Mechanistic studies on the mode of reaction of mitomycin C under catalytic and electrochemical reductive conditions Journal of the American Chemical Society. 109: 1833-1840. DOI: 10.1021/Ja00240A038  0.327
1985 Cortes S, Liao ZK, Watson D, Kohn H. Effect of structural modification of the hydantoin ring on anticonvulsant activity. Journal of Medicinal Chemistry. 28: 601-606. PMID 3989820 DOI: 10.1021/Jm50001A012  0.364
1985 Liao ZK, Kohn H. Synthesis of spiroimidazolidin-2-ones via intramolecular N-carbamoyliminium ion cyclization reactions Journal of Organic Chemistry. 50: 1884-1888. DOI: 10.1021/Jo00211A020  0.326
1985 Cortes S, Liao Z, Watson D, Kohn H. Additions and Corrections - Effect of Structural Modification of the Hydantoin Ring on Anticonvulsant Activity Journal of Medicinal Chemistry. 28: 1965-1965. DOI: 10.1021/Jm00150A604  0.311
1985 Cortes S, Liao Z-, Watson D, Kohn H. Effect Of Structural Modification Of The Hydantoin Ring On Anticonvulsant Activity Cheminform. 16. DOI: 10.1002/Chin.198534214  0.311
1985 Bean M, Kohn H. Studies on the reaction of mitomycin C with potassium thiobenzoate under reductive conditions The Journal of Organic Chemistry. 50: 293-298. DOI: 10.1002/Chin.198525374  0.744
1983 Bean M, Kohn H. Studies on the reaction of mitomycin C with potassium ethyl monothiocarbonate under reductive conditions The Journal of Organic Chemistry. 48: 5033-5041. DOI: 10.1002/Chin.198427181  0.746
1983 Hornemann U, Iguchi K, Keller PJ, Vu HM, Kozlowski JF, Kohn H. Reactions of mitomycin C with potassium ethyl xanthate in neutral aqueous solution The Journal of Organic Chemistry. 48: 5026-5033. DOI: 10.1002/Chin.198427180  0.316
1981 Kohn H, Bean MB, von Rohrscheidt C, Willcott MR, Warnhoff EW. Participation in the formation of iodo ureas from 3-buten-1-ol derivatives. A reinvestigation1 1 Alfred P. Sloan Fellow, 1977-1981. Camille and Henry Dreyfus Teacher-Scholar Grant Recipient, 1977-1982. Tetrahedron. 37: 3195-3201. DOI: 10.1016/S0040-4020(01)98853-2  0.715
1981 Flaster H, Kohn H. Syntheses and spectral properties of 2-Thiobiotin and biotin derivatives Journal of Heterocyclic Chemistry. 18: 1425-1436. DOI: 10.1002/Jhet.5570180730  0.307
1978 Arceneaux JH, Kohn H, Steenberg ML, Buckley JP. Syntheses and pharmacological activity of N-acyl-substituted imidazolidinethiones and thioimidazolines. Journal of Pharmaceutical Sciences. 67: 600-2. PMID 641789 DOI: 10.1002/Jps.2600670506  0.367
1978 Kohn H, Charumilind P, Gopichand Y. Studies of the reaction of thiocarbonyl-containing compounds with ketenes The Journal of Organic Chemistry. 43: 4961-4965. DOI: 10.1002/Chin.197918249  0.315
1977 Kohn H, Kohn BA, Steenberg ML, Buckley JP. Syntheses and pharmacological activity of substituted imidazolidinethiones and thioimidazolines Journal of Medicinal Chemistry. 20: 158-160. PMID 833815 DOI: 10.1021/Jm00211A034  0.3
1977 Kohn H, Arceneaux JH. Thermolysis of N-acyl substituted 2-allylthioimidazolines. Evidence for a [3,3] sigmatropic rearrangement The Journal of Organic Chemistry. 42: 2339-2341. DOI: 10.1002/Chin.197742178  0.326
1977 Arceneaux JH, Kohn H, Steenberg ML, Buckley JP. Syntheses And Pharmacological Activity Of N-Acyl-Substituted Imidazolidinethiones And Thioimidazolines Cheminform. 8. DOI: 10.1002/Chin.197721214  0.371
1977 Kohn H, Davis RE. Syntheses and chemistry of N-acyl substituted dihydroimidazo[2,1-b]thiazolium salts Journal of Organic Chemistry. 42: 72-77. DOI: 10.1002/Chin.197720253  0.313
1976 Breslow R, Kohn H, Siegel B. Methylated cyclodextrin and a cyclodextrin polymer as catalysts in selective anisole chlorination Tetrahedron Letters. 17: 1645-1646. DOI: 10.1016/S0040-4039(00)92912-5  0.432
1972 Kohn H, Benkovic SJ, Olofson RA. Dependence of mechanism on pH for deuterium-hydrogen exchange in 1-methyltetrazole-5-d. Transition metal ion catalysis of a deprotonation process. Journal of the American Chemical Society. 94: 5759-65. PMID 5053862 DOI: 10.1021/Ja00771A037  0.501
1972 Kohn H, Olofson RA. 1,4-Dimethyl-1,4-dihydro-1,2,4,5-tetrazine and its N-alkyl salt. Synthesis, structure, and chemistry The Journal of Organic Chemistry. 37: 3504-3509. DOI: 10.1021/jo00795a024  0.589
Show low-probability matches.